ストックスクリーナーアプリを入手
47.85
9.47%
4.14
アフターアワーズ：
48.00
0.15
+0.31%
Caredx Inc (CDNA) 最新ニュース
CareDx Inc (CDNA) Valuation: PE, PB & Fair Value Analysis - TradingKey
CDNA|CareDx Inc|Price:36.380|Chg%:-0.760 - TradingKey
BlackRock (CDNA) discloses 4.66M CareDx shares, a 9% beneficial stake - Stock Titan
CareDx CEO On Precision Diagnostics Pivot, Oncology Expansion - insights.citeline.com
CareDx Inc (CDNA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
TradingKey - TradingKey
CareDx Inc (CDNA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CareDx (CDNA) Earnings Expected to Grow: Should You Buy? - Yahoo Finance
Is CareDx (CDNA) Fully Valued After Its Medicare Coverage Win? - Sahm
This company is letting a virus guide its new focus on cancer testing - The Business Journals
CareDx (CDNA) AGM 2026 Summary - Quartr
CareDx Inc (CDNA) Shares Fall 3.4% -- GF Value Says Still Overva - GuruFocus
CareDx shares jump as Medicare finalizes transplant testing coverage policy (CDNA) - MSN
CareDx Inc (CDNA) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
CareDx Inc (CDNA) Q2 2024 Earnings ReportResults, Call & Slides - TipRanks
CareDx (CDNA) Q4 2025 earnings summary - Quartr
CareDx (CDNA) Q1 2026 earnings summary - Quartr
CareDx (CDNA) Proxy filing Summary - Quartr
CareDx (CDNA) Q3 2024 earnings summary - Quartr
CareDx’s Growth Prospects With Naveris Keep Me Bullish (NASDAQ:CDNA) - Seeking Alpha
CareDx (CDNA) Is Up 39.4% After Final Medicare Coverage Clarifies Transplant Test Reimbursement Limits - simplywall.st
CareDx (CDNA) Is Up 39.4% After Medicare Clarifies Transplant Test Coverage LimitsWhat's Changed - Yahoo Finance
CareDx (CDNA) Secures Medicare Reimbursement Clarity, Is The Upside Already Priced In? - Yahoo Finance
CareDx (CDNA) Stock May Be Fully Valued Despite Medicare Coverage News - Yahoo Finance
CareDx rallies after Medicare finalizes transplant testing coverage policy - msn.com
Form 4 Caredx Inc For: 17 July By Investing.com - Investing.com Nigeria
H.C. Wainwright reiterates Neutral stock rating on CareDx - Investing.com UK
CareDx director Hannah Valantine disposes of common shares worth $1.04 million - Bitget
H.C. Wainwright reiterates Neutral stock rating on CareDx By Investing.com - Investing.com Nigeria
CareDx CEO John Hanna sells $4.46m in company stock By Investing.com - Investing.com Nigeria
CareDx CEO John Hanna sells $4.46m in company stock - Investing.com
Form 4 Caredx Inc For: 17 July - Investing.com India
Caredx Insider Sold Shares Worth $1,040,243, According to a Recent SEC Filing - marketscreener.com
Caredx Insider Sold Shares Worth $4,458,637, According to a Recent SEC Filing - marketscreener.com
CareDx (NASDAQ: CDNA) CEO exercises options, sells 118,000 shares - Stock Titan
CareDx (CDNA) director sells 28,779 shares and exercises options - Stock Titan
A Quick Look at Today's Ratings for CareDx(CDNA.US), With a Forecast Between $35 to $45 - Moomoo
Caredx Inc (CDNA) News, Articles, Events & Latest Updates - Stocktwits
CareDx (CDNA) Moves 35.6% Higher: Will This Strength Last? - Yahoo Finance
Why Is CareDx Stock Skyrocketing Thursday? - Sahm
CAREDX INC : BTIG RAISES TARGET PRICE TO $45 FROM $28 - Bitget
BTIG raises CareDx stock price target to $45 on coverage decision - Investing.com UK
Form 144 CAREDX For: 16 July By Investing.com - Investing.com Nigeria
CareDx says final Medicare LCD maintains coverage for transplant rejection surveillance tests - Bitget
CareDx sets webcast to discuss second-quarter 2026 results after market close - Bitget
BTIG raises CareDx stock price target to $45 on coverage decision By Investing.com - Investing.com South Africa
Price to earnings forward of CareDx, Inc. – GETTEX:1K9 - TradingView
CareDx Inc. (CDNA) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Form 144 | CareDx(CDNA.US) Director Proposes to Sell 3.51 Million in Common Stocks - Moomoo
CareDx (CDNA) Jumps As Naveris Deal Redraws Growth Map - timothysykes.com
CDNA (NASDAQ: CDNA) holder John Hanna files notice to sell 118,000 shares - Stock Titan
Planned 28,779-share CDNA (NASDAQ: CDNA) sale follows earlier 10b5-1 trade - Stock Titan
Caredx Inc stock hits 52-week high at 36.4 USD By Investing.com - Investing.com South Africa
CDNA Maintained by BTIG -- Price Target Raised to $45 - GuruFocus
Caredx Inc stock hits 52-week high at 36.4 USD - Investing.com
CareDx to report Q2 2026 financial results on July 30 - scanx.trade
CareDx Announces Finalization of Solid Organ Transplant Molecular Testing Local Coverage Determination - Finviz
0.45%
1.98%
大文字化:
|
ボリューム (24 時間):